RFK Jr.s FDA Severely Restricts COVID Vaccine Use

Published: Sunday, May 18, 2025 at 11:52 am

FDA Limits Novavax COVID-19 Vaccine Access: What You Need to Know

The Food and Drug Administration (FDA) has significantly restricted the availability of the Novavax COVID-19 vaccine, sparking debate among medical professionals and raising concerns about public health. After four years of clinical trials, the vaccine is now only approved for individuals aged 12 and older who have at least one underlying medical condition that puts them at high risk from COVID-19, as well as older adults.

This decision effectively limits access for healthy adults under 65 who may wish to get vaccinated for other reasons, such as protecting vulnerable family members or friends. This contrasts with the full approval granted to Pfizer-BioNTech and Moderna vaccines in 2022, which are currently developing updated versions for the fall.

The restrictions have drawn criticism, with some suggesting they reflect Health Secretary Robert F. Kennedy Jr.'s skepticism towards vaccines. Dr. Camille Kotton, an infectious disease physician and former CDC advisor, called the decision "incredibly disappointing" and described it as a "dark day in American medicine." She questioned the rationale behind the restrictions, particularly given the potential for future, more virulent COVID-19 strains.

The move comes as the Centers for Disease Control and Prevention (CDC) advisors have been debating whether to recommend COVID vaccines for only the most vulnerable populations. This decision appears to partially resolve that question, at least concerning the Novavax vaccine.

BNN's Perspective: While the FDA's decision to restrict access to the Novavax vaccine raises valid concerns about public health and individual choice, it's crucial to acknowledge the need for ongoing evaluation of vaccine efficacy and safety. The focus should remain on ensuring access to safe and effective vaccines for those most at risk, while also considering the broader implications for public health and individual autonomy. A balanced approach that prioritizes both scientific evidence and individual needs is essential.

Keywords: FDA, Novavax, COVID-19 vaccine, vaccine restrictions, Robert F. Kennedy Jr., CDC, vaccine access, vulnerable populations, health, medical conditions, Pfizer-BioNTech, Moderna, Dr. Camille Kotton, public health, vaccine skepticism, vaccine approval.

Full Story